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KOMPLEKS DINUKLEAR ARGENTUM(I)-N-HETEROSIKLIK KARBENA 
BERDASARKAN DERIVATIF IMIDAZOLIUM: SINTESIS DAN AKTIVITI 
BIOLOGI 
 
ABSTRAK 
Kajian ini menerangkan sintesis dua siri baru, empat garam pelopor baru 
dalam siri bukan berfungsi, dinamakan, 3,3' [(1,2 fenilinbis(metilin)] bis(1-
siklopentanaimidazolium bis-heksaflorofosfat (1), 3,3' [(1,3 fenilinbis(metilin)] 
bis(1-siklopentanaimidazolium bis-heksaflorofosfat (2), 3,3' [(1,4 fenilinbis(metilin)] 
bis(1-siklopentanaimidazolium bis-heksaflorofosfat (3), 3,3' [(etana-1,2-diyl)] 
bis(siklopentanaimidazolium) bis heksaflorofosfat (4) dan empat garam sepadan 
dalam siri berfungsian nitril, dinamakan, 3,3' [(1,2 fenilinbis(metilin)] bis(4'-
benzonitrilimidazolium) bis-heksaflorofosfat (9), 3,3' [(1,3 fenilinbis(metilin)] bis(4'-
benzonitrilimidazolium) bis-heksaflorofosfat (10), 3,3' [(1,4 fenilinbis(metilin)] 
bis(4'-benzonitrilimidazolium) bis-heksaflorofosfat  (11) and 3,3' [(etana-1,2-diyl)] 
bis(4'-benzonitrilimidazolium) bis-heksaflorofosfat (12). Tindak balas garam 
imidazolium dengan argentum(I) oksida menghasilkan pembentukan dua siri baru 
kompleks argentum(I)-NHC, masing-masing, (5-8) dan (13-16). Struktur untuk 
semua sebatian disahkan dengan spektral (spektroskopi Fourier Transform 
Inframerah, spektroskopi 
1
H dan 
13
C NMR dan analisis CHN). Struktur molekular 
untuk sebatian 3, 5, 7, dan 10 dicapai menggunakan analisis sinaran-X hablur 
tunggal. Kajian antibakteria melawan bakteria Gram-positif Staphyococcus aureus 
(S. aureus) (ATCC 12600) dan Gram-negatif Escherichia coli (E. coli) (ATCC 
xvi 
 
25922) untuk kesemua 16 sebatian dijalankan. Kesemua garam imidazolium  
menunjukkan tiada perencatan manakala kesemua kompleks yang menunjukkan 
aktiviti antimikrob menunjukkan tiada perbezaan besar dalam diameter zon 
perencatan.. Kesemua garam imidazolium menunjukkan tiada perencatan manakala 
aktiviti larvisidal untuk kompleks argentum(I)-NHC. 
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DINUCLEAR SILVER(I)-N- HETEROCYCLIC CARBENE COMPLEXES 
BASED ON IMIDAZOLIUM DERIVATIVES: SYNTHESIS AND 
BIOLOGICAL ACTIVITIES 
 
ABSTRACT 
This research describes the syntheses of two new series, non-functionalized 
series of four new precursor salts , namely 3,3' [(1,2 phenylenebis(methylene)] bis(1-
cyclopentylimidazolium bis-hexaflourophosphate (1), 3,3' [(1,3 
phenylenebis(methylene)] bis(1-cyclopentylimidazolium) bis-hexaflourophosphate 
(2), 3,3' [(1,4 phenylenebis(methylene)] bis(1-cyclopentylimidazolium) bis-
hexaflourophosphate (3), 3,3' [(ethane-1,2-diyl)] bis(1-cyclopentylimidazolium) bis-
hexaflourophosphate (4) and nitrile functionalized series of four new correspondence 
salt, namely 3,3' [(1,2 phenylenebis(methylene)] bis(4'-benzonitrilelimidazolium) 
bis-hexaflourophosphate (9), 3,3' [(1,3 phenylenebis(methylene)] bis(4'-
benzonitrilelimidazolium) bis-hexaflourophosphate (10), 3,3' [(1,4 
phenylenebis(methylene)] bis(4'-benzonitrilelimidazolium) bis-hexaflourophosphate 
(11) and 3,3' [(ethane-1,2-diyl)] bis(4'-benzonitrilelimidazolium) bis-
hexaflourophosphate (12). Reaction of respective imidazolium salts with silver(I) 
oxide afforded the formation of two new series of silver(I)-NHC complexes, (5-8) 
and (13-16), respectively. The structures of all the compounds were confirmed by the 
elemental analysis data, (Fourier Transform Infrared spectroscopy, 
1
H and 
13
C NMR 
spectroscopy and CHN analysis). Selected molecular structure of compounds 3, 5, 7, 
and 10 were established by single crystal X-ray diffraction analysis. The antibacterial 
studies against the Gram-positive Staphyococcus aureus (S. aureus) (ATCC 12600) 
xviii 
 
and Gram-negative Escherichia coli (E. coli) (ATCC 25922) of all sixteen 
compounds were carried out. All the imidazolium salts show no inhibition while all 
complexes displayed antimicrobial activity shows no huge difference in the diameter 
of the zone of inhibition. On the other hand, larvicidal activities against Ae. aegypti 
and Cx. Quinquefasciatus showed no inhibition for imidazolium salts but their  
silver(I)-NHC complexes showed larvicidal activity. Therefore, this study quantified 
the larvicidal property of silver(I)-NHC complexes, providing information on lethal 
concentration that have potential for the control of mosquitoes. 
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CHAPTER 1 
INTRODUCTION 
1.1 Persistent Carbenes 
Carbenes are compound containing a neutral divalent carbon atom with two 
non-bonding electrons and six valence electrons, which the two unshared electrons 
can be assigned to nonbonding orbitals in different ways [1] (Figure 1.1) . 
C
R'
R''
 
Figure 1.1: A general representation of carbene. 
 
The existences of carbenes are depending on the electronic spins they possess 
(singlet or triplet states). Singlet state carbene has two unshared electrons paired spin 
adopts sp2-hybridization in the same orbital (Figure 1.2). Triplet state carbene have 
unshared electrons arranged in two different orbitals with parallel spins and adopts 
the sp-hybridization (Figure 1.2) [2]. Triplet carbenes considered as diradicals 
because of their two unpaired electrons [3]. The ground state spin multiplicity can be 
determined by the relative energies of σ and pπ orbitals. According to Hoffmann, the 
energy differences greater than 2 eV is favored to be a singlet carbenes while the 
energy difference below 1.5 eV lead to a triplet ground state [4]. 
R
R'
Singlet state
(a)
                            
R
R'
Triplet state
(b)
 
Figure 1.2: Electronic states of carbenes, (a) singlet state; (b) triplet state. 
 2 
 
The energy difference gap can be increased by the existence of σ-electron 
withdrawing substituents adjacent to the divalent carbon atom. Thus, these groups 
will stabilize the σ-nonbonding orbital by increasing s orbital character, while 
leaving the pπ orbital unchanged [5]. 
 
1.2 N-Heterocyclic carbene (NHC) 
In early 1960, Wanzlick investigated saturated and unsaturated heterocyclic 
carbenes. The focus was first to synthesize C-C saturated molecules of type 3 
(Scheme 1.1). However, Wanzlick could never isolate 3 and always obtained 2, 
which acquired from the α-elimination reaction of chloroform from 1 [6].  
 
N
C
N H
CCl3
C6H5
C6H5
N
C
N
C
N
N
N
C
N
C6H5 C6H5
C6H5C6H5
C6H5
C6H5
-CHCl3
2
1
2 3  
Scheme 1.1: Formation of dimeric entatraamine 2 instead of free NHC 3. 
 
 Later, Wanzlick tried to separate the dimeric entatramine, 2 using cross-
metathesis method, however unsuccessful [7]. In 1970, Wanzlick changed the 
starting material to facilitate the formation of free NHC. In his intention to prepare 
carbene 5, Wanzlick tried to deprotonate 1,2,3,4,5-tetraphenylimidazolium 
perchlorate, 4 with base catalysed medium, KOtBu (Scheme 1.2), but the reaction 
could not be isolated as this method was detected as the intermediate product [8]. 
 3 
 
N
CH
N
C6H5
C6H5
C6H5
C6H5
N
C
N
C6H5
C6H5
C6H5
C6H5
ClO4
-
KOtBu
-KX,-HOtBu
4 5  
Scheme 1.2: Deprotonation of imidazolium salt from 4 to free carbene 5. 
 
  Various efforts have been applied on synthesis and isolation of carbenes by 
researchers until pioneering studies in the late 1980s and early 1990s [9]. In 1991, 
Arduengo believed that the intermediate carbenes are unstable as being assumed by 
other researchers [10]. Arduengo and co-workers synthesized and isolated the first 
crystallogaphically explained NHC, 7 from an azolium salt, 6 in the presence of 
sodium hydroxide and DMSO using THF as reaction medium (Scheme 1.3) [11]. 
This carbene was found to be stable at room temperature in the absence of moisture 
and oxygen [12]. Further in 1998, Arduengo prepared, characterized and determine 
the single crystal structure of carbene, 5 which Wanzlick could not isolate in 1968 
[13]. 
N N N
N
C
H
Cl- NaH/THF,
Cat, DMSO
,-NaCl, -H2
6
7
H2(g) NaCl(s)
 
Scheme 1.3: First isolated carbene ion 7 from azolium salt 6. 
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1.3 The stability of NHCs 
Formerly, Arduengo stated that the stability of NHCs is due to the steric 
hindrance of the bulky N-adamantyl substituents which prevent the dimerization of 
the carbene. Nevertheless, Arduengo’s syntheses of another stable carbene with N-
methyl substituents proved this wrong [14]. Arduengo believed that the electronic 
contributions are the main factors in determining the stability of NHC and its 
complexes (Figure 1.3). Electronic contributions involve electron donation from the 
adjacent nitrogen atoms to the vacant pπ orbital of the carbene carbon. Moreover, 
due to higher electronegativity of nitrogen as compare to carbon atom, charge 
density is considered to be inductively withdrawn through the σ-framework, 
stabilizing the carbene lone pair [14].  
e- donation
(resonance effect)
vacant p-orbital
unshared electron
e- withdrawal
(inductive effect)  
(a) 
N
N
N
N
N
N
R
R
R
R
R
R
N
N
R
R
N
N
R
R
 
(b) 
Figure 1.3: (a) Electronic and (b) resonance stabilization in N-heterocyclic carbene. 
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Even NHCs are viewed mainly as σ–donor; recent theoretical and structural 
studies suggest the existence of some π–backbonding for certain metal centre (Figure 
1.4). The electron donation makes NHC as nucleophilic character and gives them 
good σ-donors to transition metals in low and high oxidation states. In comparison to 
the Fischer and Schrock carbenes, NHCs are stable, capable of independent 
existence and can be readily prepared. 
M C
N
N
 
Figure 1.4: Metal bonding to N-heterocyclic carbene. 
 
1.4 Types of NHC ligands 
There are several variation of NHC based on their structures. Examples of 
NHC are imidazole-2-ylidine, imidazolidin-2-ylidenes, imidazole-5-ylidenes, 1,2,4-
trazolodin-3,5-ylidenes, tetrahydropyramid-2-ylides and benzimidazol-2-ylidene. 
Among them, the five membered NHC are the most commonly studied (Figure 1.5). 
N N
R R
N N
R R
N N
R R
N N
R R
N N
R R
R
R
N N
R R
imidazole-2-ylidine imidazolidin-2-ylidenes imidazole-5-ylidenes
1,2,4-trazolodin-3,5-ylidenes tetrahydropyramid-2-ylides benzimidazol-2-ylidene 
Figure 1.5: Type of N-heterocyclic carbene. 
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1.5 Synthesis of azolium salts: The NHC precursors 
NHC precursors are prepared by two common routes [15]: 
 
a) Nucleophilic substitution starting at the azole heterocycle 
This route involves alkylation of azole (imidazole, benzimidazole, triazole 
etc) reacted with strong base such as KOH and NaOH. The potassium or sodium 
azolide formed is then treated with one equivalent of alkyl or aryl halide in a suitable 
solvent to obtain N-alkyl/aryl substituted azole [16]. The N-substituted azole is then 
reacted with one equivalent of alkyl or aryl halide to yield disubstituted of 
imidazolium salts (Scheme 1.4). 
 
NHN NKN NN NN
R' "R R'KOH
DMSO, RT
-H2O
R'-X
DMSO,RT
-KX
R"-X
Solvent,reflux
imidazole potassium azolide 1-alkylimidazole
1,3-dialkylimidazolium 
               halide
 
Scheme 1.4: General representation of syntheses of imidazolium salts by 
nucleophilic substitution. 
 
 
b) Multi-components reaction, building up the heterocycle with the appropriate 
substituents in one step 
This route which involves one pot synthesis using primary amines, glyoxal, 
and formaldehyde are reacted in the presence of Brønsted acid [17, 18]. The reaction 
starts with coupling between amine and glyoxal to form Schiff base. Further, 
condensation with formaldeyde which facilitates the formation of imidazolium salt 
(Scheme 1.5).  
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O O
2 R-NH2
N N RR
O
HH
NN
R R-2H2O
HX
-H2O
X-
 
Scheme 1.5: General representation of syntheses of imidazolium salts by multi-
components reaction. 
 
The flexible route is suitable for the syntheses of symmetrical 1,3- substituted 
azolium salts. Unsymmetrical substituted azolium salts can also be prepared by the 
combination of a multicomponent cyclization and follow with an N-alkylation 
reaction [19]. After the alkylation, alkyl group (R”) attached at second nitrogen atom 
to obtain asymmetrically substituted derivative (Scheme 1.6). 
HO OH
NN
"R R'
X-
NHN
R'
X-+   [R'-NH3]X
+   [NH2]Y
+   CH2O
H+
Base
"R-X
H-X
 
Scheme 1.6: General representation of multicomponent cyclization and N-alkylation. 
 
1.6 Synthesis of silver(I)-NHC complexes 
NHCs have been extensively used in organometallic and inorganic chemistry 
for catalytic study [20] , transmetalation [21] and medicinal studies [22]. Three main 
synthetic methods are used to synthesis silver(I)-NHC complexes:  
 
1.6.1 Preparation of the free carbene and reaction with silver salt  
The first reported synthesis of silver(I) complex was achieved by this route in 
1993. According to this route, deprotonation of imidazolium salt  prepared with 
strong base  and subsequently free carbon reacted with silver triflate to yield silver-
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NHC complex (Scheme 1.7) [23]. Since then, various silver(I) complexes have been 
synthesized using this method [24-26]. A strong base suitable for deprotonation of 
imidazolium salts is either potassium hydride, KH or potassium t-butoxide, KOtBu. 
As this route in the initial stage of free carbenes, it is limited to those imidazolium 
salts which can generate stable carbenes [24, 27-29]. 
N
N
N
N
N
N
Ag
N
N
KH
or
KOtBu
CF3SO3
-
AgO3SCF3
 
Scheme 1.7: Preparation of silver(I)-NHC complexes by free carbene. 
 
1.6.2 In-situ reaction of azolium salts 
Deprotonation of azolium salt by the use of a silver(I) base such as Ag2O, 
AgOAc, and Ag2CO3 [30, 31] has been the most widely used method in the syntheses 
of silver(I)-NHC complexes. Lin and co-workers investigated a procedure that using 
Ag2O to form silver(I)-NHC complexes of 1, 3 diethylbenzimidazol– 2–ylidene  
(Scheme 1.8) [32, 33]. Silver oxide is the most frequently used of the metal bases as 
the reaction can easily controlled by removing insoluble silver oxide [34-38]. 
Different sorts of solvents have been used with Ag2O in the synthesis of silver(I)-
NHC complex such as dimethylformamide, dichloromethane, 1,2-dichloroethane, 
dimethyl sulfoxide, acetonitrile, methanol and acetone. 
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N
N
Et
Et
N
N
Et
Et
Ag
N
N
Et
Et
N
N
Et
Et
Ag
N
N
Et
Et
Ag
Br
Br
X-
PF6
-
Ag 2
O
X=
Br
--
Ag
2 O
X=PF
6 -
PF6
-
 
Scheme 1.8: In-situ reaction of benzimidazolium salts. 
 
1.6.3 Silver salt in the basic medium 
 
An alternative method to synthesize silver(I)-NHC complexes is through the 
deprotonation of imidazolium cations that was first employed by Wang and Lin [32]. 
These researchers used a basic phase transfer catalyst, tetrabutylammonium bromide 
(Bu4N
+Br-) to prepare 8 from imidazolium bromide in the presence of silver bromide 
(Scheme 1.9). The silver(I)-NHC complexes produced through this method are 
sensitive to moisture which leads to decomposition to imidazolium salt.  Thus, this 
routes have been abandoned due to unsuccessful attempts and the aforementioned 
success of silver-based route using silver(I) oxide [39].  
 
 
Scheme 1.9: Synthesis of silver(I)-NHC, 8 using basic phase transfer catalyst. 
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1.7 Applications of silver(I)-NHC complexes 
1.7.1  Catalytic study 
In 1996, Fernandez, Peris and co-workers were the first to study silver(I) 
NHC as donation from the substituents of the alkene by increasing the conversion 
rates of the diboration reaction. Later, they found that increasing the temperature of 
the diboration reaction, it slows the conversion of the alkene to the diborane. 
However, the active catalytic species of silver(I)-NHCs could not discover as the 
nature of silver(I)-NHC in solution. 
Later, Waymouth and Hedrich have also studied silver(I)-NHCs for catalytic 
purposes [40]. They reported that silver(I)-NHCs, 9 undergoes thermolysis to 
produce free NHC (Scheme 1.10), which then used to catalyse the ring opening 
polymerization of L-lactide [41]. The thermal stability of 9 was studied by different 
scanning calorimetry and thermogravimetric analysis. They attempted to trap the free 
NHCs by heating complex 9 in the presence of a trapping reagent, carbon disulphide 
to produce zwitterion 10. 
 
N
N
Ag
N
N
N
N S
S-
AgCl2
-
CS2,
THF
-2AgCl
9 10  
Scheme 1.10: Active catalytic species of silver(I)-NHC. 
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1.7.2 Carbene transfer chemistry 
One of the most important application of silver(I)-NHC is transmetalation 
reaction. Many ligands are unsuccessfully metalate due to degradation under 
condition required. Silver(I)-NHC complexes  have proven themselves as transfer 
agent to other metals such as Au(I), Cu(I), Cu(I), Pd(II), Pt(II), Ni(II), Ir(I), Ir(III), 
Rh(I), Rh(III), Ru(II), Ru(III), and Ru(IV). Transmetalation reaction can be carried 
out under aerobic conditions, inert atmosphere and presence of water [42]. 
Transmetallation become more important method in obtaining the NHC complexes 
of different metal with interesting biological applications [43]. 
Transmetalation from silver(I)-NHCs has become a general method for 
preparation of Pd(II)-NHCcomplexes where a variety of palladium reagents have 
been used for transmetalation including Pd(COD)Cl2 [44-47], Pd(COD)Br2 [48], 
Pd(COD)CH3Br [48], Pd(COD)CH3Cl [29, 44, 47-49], PdCl2 [50-52], [Pd(allyl)Cl]2 
[53-55], PdCl2(CH3CN)2 [50, 56-59], and PdCl2-(PhCN)2 [44, 60] (Scheme 1.11). 
(a) 
N N
N
R
R
Ag
Br
N
N
N
R
R
Pd
Br
Br
CH2Cl2
Pd(COD)CH3Br
 
(b) 
R N N R
Ag
Br
R N N R
Br-
Ag2O
PdCl2(MeCN)2
Pd
R R
RR
ClCl
 
Scheme 1.11: Transmetalation of silver(I) complexes: (a) Using Pd(COD)CH3Br  
[48], (b) Using PdCl2(CH3CN)2 [58]. 
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1.7.3 Medicinal chemistry 
a)  The use of silver compounds as antimicrobials 
Silver has been used as an antimicrobial in early years. The early civilizations 
used silver to store and purify drinking water [61-64]. Antimicrobial properties of 
silver nitrate were known in 1800s and it was recognized as an antiseptic in wound 
care for more than 200 years. In the late 19th century, it was reported that silver 
compounds can kill certain microorganisms at very low concentrations [65]. Créde 
began to use of 2% silver nitrate solution to prevent eye infections in new-borns, in 
1881.  
In 20th century, colloidal silver solutions were introduced to avoid the 
irritation associated with silver nitrate. Moyer found a treatment for large human 
burns using 0.5% silver nitrate solution [66]. In addition, Fox discovered the use of 
silver antibiotics using silver sulfadiazine [67] . Silver sulfadiazine (Figure 1.6) is 
designed to combine antibiotic sulphonamide, sulfadiazine, with silver to obtain 
wide spectrum antibiotics. It is in solid state, water insoluble complex and exists as 
polymer. Besides, it has been shown good biological activities against gram- positive 
and gram-negative bacteria [68]. Silver sulfadiazine remains one of most widely 
used antimicrobials for infections associated with burns [22]. 
 
 
 
Figure 1.6: Structure of silver sulfadiazine [67]. 
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Silver sulfadiazine have been observed to kill bacteria quickly, but loose their 
effect in a short time causing the wound site to be reinfected. The slow release of 
silver at the wound sites is essential for faster healing. The strong binding of NHCs 
to silver can result in more stable complexes that can slowly release silver ion, thus 
retaining the antimicrobial effect over a longer period of time. 
 
b)  The use of silver compounds as larvacides 
Silver(I)-NHC complexes have been widely tested for their antimicrobial 
activities. However, they were rarely studied for their antilarvacidal activity.  
 
At present, different types of metal nanoparticles are being produced 
including copper, zinc, titanium, magnesium, gold, alginate and silver [69].Among 
these, silver nanoparticles (AgNPs) have received considerable attention due to their 
attractive physico-chemical properties, surface plasmon resonance, surface-enhanced 
raman scattering (SERS) or biological applications. Biologically synthesised AgNPs 
have many applications, including for both in vivo and in vitro biomedical and 
industrial research. Addition to this, the AgNPs act as the very good insecticide for 
the control of mosquito vectors nowadays [70]. Thus, a novel attempt to test 
silver(I)-NHC against mosquito larvae have been reported.  
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1.8 Research Problem 
1.8.1 This research problem of this project are to: 
 
i. Evaluate angle and coordination of C-Ag-C geometry upon completion of 
silver(I)-NHC complexes using X ray diffraction analysis. 
ii. Investigate coordination bond between nitrile groups after formation of 
silver(I)-NHC complexes. 
iii. Examines the release rate of silver ion towards antimicrobial and larvicidal 
activities. 
1.9 Proposed work 
1.9.1 The objectives of this project are :- 
i. To syntheses new N-heterocyclic carbenes (NHC) ligands of xylyl 
(ortho/meta/para) linked bis-imidazolium salt with cyclopentyl and 1,4-
bromomethyl benzonitrile. 
ii. To syntheses binuclear silver(I)-NHC complexes derives from xylyl 
(ortho/meta/para) linked bis-imidazolium salts. 
iii. To characterize the ligands and complexes using elemental analysis and 
single crystal X ray diffraction analysis for selected compounds. 
iv. To evaluate the antimicrobial and larvicidal activities of all synthesized 
imidazolium salts and silver(I)-NHC complexes. 
 
1.9.2 Targeted imidazolium compounds 
For this research, imidazole was used as a starting material. The targeted 
ligands are bidentate consist one substituent of either cyclopentyl or benzonitrile 
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bridged with different xylyl halide and dibromoethane as their halide salts. The 
prepared imidazolium salt were then used to produce dinuclear silver(I)-NHC 
complexes (Scheme 1.12). The synthesised compounds were characterised using 
spectral and analytical methods. Structure of compound 3,5,7 and 10 were confirmed 
using single crystal X-ray diffraction techniques. Then, all the compounds were 
evaluated for their antimicrobial studies and larvicidal activities.  
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               Scheme 1.12:  General scheme of bis- imidazolium salts (1-4, 9-12) and their respective silver(I)-NHC complexes (5-8, 13-16).
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CHAPTER 2 
EXPERIMENTAL 
2.1 Materials 
 Imidazole (Merck, for synthesis), 1-bromocyclopentane (Merck, for 
synthesis), 1,2-dibromoethane (Sigma Aldrich, 99%), 4-(bromomethyl) benzonitrile 
(Sigma Aldrich, 99.0%), potassium hydroxide pellets (R&M chemicals,85%), 
potassium hexafluorophosphate (Across Organic, 99.0%), silver(I) oxide (Merck, 
99.0%), Celite (Merck, size: 0.02-0.1 mm), dimethyl sulphoxide (QRëC), 
chloroform (QRëC), 1,4- dioxane (QRëC), methanol (QRëC), acetonitrile (QRëC), 
and diethyl ether (QRëC) were purchased from commercial sources and were used as 
received.  
2.2 Instruments 
 The melting point was taken using a Stuart Scientific SMP-1 (UK) 
instrument. Elemental analysis was recorded on a Perkin Elmer Series II, 2400 
microanalyzer. The Frontier Transforms Infrared (FT-IR) spectra were carried out in 
potassium bromide disks using a Perkin Elmer 2000 system spectrometer in the 
range of 4000 cm to 400 cm-1. Nuclear Magnetic Resonance (NMR) spectra were 
recorded in d6-DMSO d3-acetonitrile using Bruker 500-MHz Ascend spectrometers 
at ambient temperature with TMS as an internal standard. The 1H- and 13C-NMR 
peaks are labelled as singlet (s), doublet (d), triplet (t), or multiplet (m). Chemical 
shifts are assigned with respect to  NMR solvent signals. 
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2.3 Synthesis of non-functionalized compounds 
2.3.1 Synthesis of N-cyclopentyl imidazole 
NN
 
 The N-cyclopentyl imidazole compound was synthesized according to the 
reported procedure [71].  The potassium azolide salt of imidazole was obtained by 
stirring imidazole with strong base potassium hydroxide in DMSO at room 
temperature. Cyclopentyl bromide subsequently was then added dropwise in the 
same reaction medium. The synthesized product yields in 84-92%.  
 
2.3.2  Synthesis of non-functionalized bis-imidazolium salts (1-4) 
2.3.2(a) Synthesis of 3,3' [(1,2 phenylenebis(methylene)] bis(1-
cyclopentylimidazolium) bis-hexaflourophosphate (1) 
 
 
The obtained N-cyclopentyl imidazole (1.00 g, 7.30 mmol) was dissolved in 
1,4-dioxane (40 mL). 1,2-dibromomethyl benzene (0.96 g, 3.64 mmol) was added to 
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the solution and refluxed at 100 °C for 24 h. The reaction was then cooled to room 
temperature. The white precipitates were filtered and washed with fresh 1,4-dioxane 
(3 x 5 mL) and diethyl ether (2 x 5 mL) to remove by-product. For further synthesis 
procedure, halide salt was used while for characterization purpose, the 
hexafluorphosphate salt of the compound was prepared. Bromide salt was directly 
converted into its hexafluorophosphate counterpart by metathesis reaction using two 
equivalent of KPF6 in methanol (50 mL). The mixture was stirred for 3 h and 
filtered, washed with distilled water (3 x 5 mL) and then recrystallized from 
acetonitrile. Salt 1 was collected as white powder. 
Yield: 2.10 g (86.7 %); MP: 181-183 °C; Anal. Calcd. of C24H32F12N4P2: C, 43.12; 
H, 4.80; N, 8.40. Found: C, 43.52; H, 4.69; N, 8.27; FT-IR (KBr, cm-1); 3177 (C-
Haromatic, 1567 (C=C), 1456 (C-N); 1H NMR (500 MHz, d6-DMSO): δ 1.85 (16H, m, 
Cyclopentyl 8×CH2), 4.78 (2H, m, Cyclopentyl  2×CHN), 5.56 (4H, d, 2×NCH2, 
J=9.5 Hz), 7.44 (4H, m, 4×imid H), 7.81 (4H, m, 4×Ar H), 9.26 (2H, s, 2×NCHN); 
13C NMR (125 MHz, d6-DMSO): 23.1, 32.5 (Cyclopentyl 8×CH2), 49.1 
(Cyclopentyl  2×CHN), 60.8 (2×NCH2), 121.6, 122.8 (4×imid C), 129.7, 132.7, 
(4×Ar C), 135.7 (2×NCHN). 
 
2.3.2.2 Synthesis of 3,3' [(1,3 phenylenebis(methylene)] bis(1-
cyclopentylimidazolium) bis-hexaflourophosphate (2) 
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Compound 2 was prepared in a manner analogous to that resulting 1, but 
using 1,3-dibromomethyl benzene (0.96 g, 3.64 mmol) instead of 1,2-dibromomethyl 
benzene. Salt 2 was collected as white powder. 
Yield: 2.33 g (95.8 %); MP: 178-180 °C; Anal. Calcd. of C24H32F12N4P2: C, 43.12; 
H, 4.80; N, 8.40. Found: C, 43.33; H, 4.72; N, 8.24; FT-IR (KBr, cm-1);  3115 (C-
Haromatic, 1561 (C=C), 1456 (C-N); 1H NMR (500 MHz, d6-DMSO): δ 1.97 (16H,  m, 
Cyclopentyl 8×CH2), 4.77 (2H, m, Cyclopentyl 2×CHN), 5.41 (4H, s, 2×NCH2), 
7.49 (4H, m, 4×imid H), 7.82 (4H, m, 4×Ar H), 9.33 (2H, s, 2×NCHN); 13C NMR 
(125 MHz, d6-DMSO): 22.0, 31.6 (Cyclopentyl 8×CH2), 50.7 (Cyclopentyl 2×CHN), 
59.8 (2×NCH2), 121.6 (4×imid C), 127.1, 127.6, 128.8 (4×Ar C), 134.3 (2×NCHN). 
 
2.3.2.3 Synthesis of 3,3' [(1,4 phenylenebis(methylene)] bis(1-
cyclopentylimidazolium) bis-hexaflourophosphate (3) 
 
Compound 3 was prepared in a manner analogous to that resulting 1, but 
using 1,4-dibromomethyl benzene (0.96 g, 3.64 mmol) instead of 1,2-dibromomethyl 
benzene. Salt 3 was collected as white powder. Colourless crystals of 3 were 
obtained by re-crystallization from acetonitrile. 
Yield: 2.23 g (91.6 %); MP: 176–179 °C; Anal. Calcd. of C24H32F12N4P2: C, 43.12; 
H, 4.80; N, 8.40. Found: C, 43.32; H, 4.90; N, 8.21; FT-IR (KBr, cm-1); 3170 (C-
Haromatic, 1432 (C=C), 1356  (C-N); 1H NMR (500 MHz, d6-DMSO,): δ 2.10 (16H,  
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m, Cyclopentyl 8×CH2), 4.77 (2H, t, Cyclopentyl 2×CHN, J=7.0 Hz), 5.41 (4H, s, 
2×NCH2), 7.50 (4H, s, 4×imid H), 7.8 (2H, s, 2×Ar H), 7.86 (2H, s, 2×Ar H), 9.37 
(2H, s, 2×NCHN); 13C NMR (125 MHz, d6-DMSO): 23.1, 32.5 (Cyclopentyl 
2×CH2), 51.6 (Cyclopentyl 2×CHN), 60.8 (2×NCH2), 121.7 (4×imid C), 122.6, 
128.9, (4×Ar C), 135.3 (2×NCHN). 
 
2.3.2.4 Synthesis of 3,3' [(ethane-1,2-diyl)] bis(1-cyclopentylimidazolium) bis-
hexaflourophosphate (4) 
N
N
NN
2PF6
-
 
Compound 4 was prepared in a manner analogous to that resulting 1, but 
using 1,2-dibromoethane (0.69 g, 3.64 mmol) instead of 1,2-dibromomethyl 
benzene. Salt 4 was collected as brown solid.  
Yield: 1.96 g (90.6 %); MP: 190–193. °C; Anal. Calcd. of C18H30F12N4P2: C, 36.21; 
H, 5.08; N, 9.49. Found: C, 36.55; H, 5.28; N, 9.22; FT-IR (KBr, cm-1); 3166 (C-
Haromatic, 1565 (C=C), 1463 (C-N); 1H NMR (500 MHz, d6-DMSO): δ 1.95 (16H,  m, 
Cyclopentyl 8×CH2), 4.65 (4H, s, NCH2CH2N), 4.73 (2H, m, Cyclopentyl 2×CH), 
7.60 (2H, s, imid H), 7.85 (2H, s, imid H), 9.11 (2H, s, 2×NCHN); 13C NMR (125 
MHz, d6-DMSO): 32.4, 23.0 (Cyclopentyl 8×CH2), 48.5 (Cyclopentyl 4×CHN), 60.9 
(NCH2CH2N), 121.7, 122.6, (imid-C), 135.6 (2×NCHN).  
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2.3.3 Synthesis of non-functionalized silver (I)-NHC complexes (5-8) 
 
2.3.3(a) Synthesis of 3,3'-[1,2-phenylenebis(methylene)] bis(1-
cylopentylimidazolium) disilver(I) bis(hexaflourophosphate)(5) 
 
NN
NN
AgAg
NN NN
2 PF6
-
2+
 
 
        A mixture of bromide salt 1 (0.50 g, 0.93 mmol) and Ag2O (0.50 g, 1.86 mmol) 
were dissolved in methanol (30 mL) and left to stir at room temperature for 48 h, 
covered from light. The reaction mixture was then filtered through Celite and the 
clear filtrate was collected. The filtrate was stirred with KPF6 (0.30 g, 1.63 mmol) in 
methanol (20 mL), which then facilitated the formation of 5 as white powder. The 
product was filtered, washed with distilled water and dried under vacuum. Single 
crystals were obtained by recrystalization in a mixture of acetonitrile:1,4-dioxane at 
room temperature. 
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Yield: 0.76 g (65.7 %); MP: 179-181 °C; Anal. Calcd. of C48H60Ag2F12N8P2: C, 
45.90; H, 4.78; N, 8.93. Found: C, 45.92; H, 4.70; N, 8.80; FT-IR (KBr, cm-1); 
3130 (C-Haromatic), 1560 (C=C), 1424 (C-N); 1H NMR (500 MHz, d6-DMSO): δ 1.82 
(32H,  m, Cyclopentyl 16×CH2), 4.52 (4H, s, Cyclopentyl 4×CHN), 5.37 (8H, s, 
4×NCH2), 7.17 (4H, s, 4×Ar H), 7.42 (8H, s, 8×imid H), 7.62 (4H, s, 4×Ar H); 13C 
NMR (125 MHz, d6-DMSO): 23.6, 30.6, 33.5 (Cyclopentyl 16×CH2), 51.8 
(Cyclopentyl 4×CHN), 62.4 (4×NCH2), 120.0, 122.4 (8×imid C), 128.9, 129.1, 
134.4, (8×Ar C), 179.6, 179.6, 178.2, 178.1 (4×NCHN). 
 
2.3.3(b) Synthesis of 3,3'-[1,3-phenylenebis(methylene)] bis(1-
cylopentylimidazolium) disilver(I) bis(hexaflourophosphate) (6) 
2PF6
-
NN
NN
Ag Ag
N N N
N
2+
 
Complex 6 was prepared in a manner analogous to that resulting 5, but using 
compound 2 (0.50 g, 0.93 mmol) instead of 1. The product of 6 was collected as 
brown solid. 
 
 Yield: 0.85 g (72.8 %); Anal. Calcd. of C48H60Ag2F12N8P2: C, 45.90; H, 4.78; N, 
8.93%. Found: C, 45.56; H, 4.60; N, 8.61%; FT-IR (KBr, cm-1); 3144 (C-Haromatic, 
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1452 (C=C), 1422 (C-N); 1H NMR (500 MHz, d6-DMSO): δ 1.98 (32H,  m, 
Cyclopentyl 16×CH2), 4.77 (4H, s, Cyclopentyl 4×CHN), 5.13 (8H, d, 4×NCH2), 
7.08 (4H, s, 4×Ar H), 7.19 (8H, s, 8×imid H), 7.29 (4H, s, 4×Ar H); 13C NMR (125 
MHz, d6-DMSO): 33.5, 23.6 (Cyclopentyl 16×CH2), 53.9 (Cyclopentyl 4×CHN), 
62.5 (4×NCH2), 119.7, 122.6 (8×imid C), 129.4, 134.6, (8×Ar C), 179.1 (4×NCHN). 
 
2.3.3(c) Synthesis of 3,3'-[1,4-phenylenebis(methylene)] bis(1-
cylopentylimidazolium) disilver(I) bis(hexaflourophosphate) (7) 
N NN
N
Ag Ag
N N N N
2PF6
-
2+
 
Complex 7 was prepared in a manner analogous to that resulting 5, but using 
compound 3 (0.50 g, 0.93 mmol) instead of 1. The product of 7 was collected as a 
beige powder. The colorless crystals of 7 were obtained from re-crystallization in 
acetonitrile. 
 Yield: 0.80 g(68.4 %); MP: 171–173 °C; Anal. Calcd. of C48H60Ag2F12N8P2: C, 
45.90; H, 4.78; N, 8.93%. Found: C, 45.90; H, 4.72; N, 8.90%; FT-IR (KBr, cm-1); 
3168 (C-Haromatic), 1518 (C=C), 1452 (C-N); 1H NMR (500 MHz, d6-DMSO): δ 2.01 
(32H,  m, Cyclopentyl 16×CH2), 4.85 (4H, s, Cyclopentyl 4×CHN), 5.22 (8H, s, 
4×NCH2), 7.13 (8H, s, 8×imid H), 7.26 (4H, s, 4×Ar H), 7.31 (4H, s, 4×Ar H); 13C 
